Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Med Genet. 1998 Oct 2;79(4):279-83.

Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome.

Author information

1
Istituto di Genetica Medica, Facoltà de Medicina A. Gemelli, Università Cattolica, Roma, Italy. ibige@rm.unicatt.it

Abstract

The Simpson-Golabi-Behmel syndrome (SGBS) is an overgrowth/multiple congenital anomalies/dysplasia syndrome caused by a mutant X-linked gene. The spectrum of its clinical manifestations is broad, varying from very mild forms in carrier females to infantile lethal forms in affected males. A typically affected male will show tall stature, "coarse" face, supernumerary nipples, congenital heart defect, and generalized muscular hypotonia. Mental development is normal in most cases. There is an increased risk of neoplasia in infancy, especially Wilms tumor. The SGBS gene spans 500 kilobases in the Xq26 region and contains eight exons. It encodes an extracellular proteoglycan, designated glypican 3 (GPC3), capable of interacting with the insulin-like growth factor IGF2. At present, only deletions of various sizes have been found in a number of affected families.

PMID:
9781908
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center